Tower Research Capital (TRC)’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-48
| Closed | -$4 | – | 5701 |
|
|
2024
Q4 | $4 | Hold |
48
| – | – | ﹤0.01% | 5640 |
|
|
2024
Q3 | $2 | Hold |
48
| – | – | ﹤0.01% | 5665 |
|
|
2024
Q2 | $2 | Hold |
48
| – | – | ﹤0.01% | 5638 |
|
|
2024
Q1 | $2 | Hold |
48
| – | – | ﹤0.01% | 5814 |
|
|
2023
Q4 | $1 | Hold |
48
| – | – | ﹤0.01% | 5894 |
|
|
2023
Q3 | $4 | Hold |
48
| – | – | ﹤0.01% | 5889 |
|
|
2023
Q2 | $5 | Hold |
48
| – | – | ﹤0.01% | 5951 |
|
|
2023
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 6216 |
|
|
2022
Q4 | $0 | Hold |
48
| – | – | ﹤0.01% | 6305 |
|
|
2022
Q3 | $0 | Hold |
48
| – | – | ﹤0.01% | 6424 |
|
|
2022
Q2 | $0 | Hold |
48
| – | – | ﹤0.01% | 6464 |
|
|
2022
Q1 | $0 | Hold |
48
| – | – | ﹤0.01% | 6488 |
|
|
2021
Q4 | $0 | Buy |
+48
| New | – | ﹤0.01% | 6519 |
|